Trials / Completed
CompletedNCT01192854
An Study of Efficacy and Safety of Clevudine
A Multi-center, Randomized, Double-blind, Positive-control, Phase III Trial of the Efficacy and Safety of Clevudine
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 288 (actual)
- Sponsor
- Eisai Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Randomized, double blind parallel group, positive control, multi-center trial. Patients will be randomized at 1:1 ratio in group A or group B
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clevudine | Clevudine flexible dosages of 30 mg/day |
| DRUG | Adefovir | Adefovir flexible dosages of 10 mg/day |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2011-05-01
- Completion
- 2011-05-01
- First posted
- 2010-09-01
- Last updated
- 2013-05-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01192854. Inclusion in this directory is not an endorsement.